Підписатись
Borikun Tetiana
Borikun Tetiana
RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of
Підтверджена електронна адреса в onconet.kiev.ua
Назва
Посилання
Посилання
Рік
Association of cd44⁺ cd24⁻/low with markers of aggressiveness and plasticity of cell lines and tumors of patients with breast cancer
VF Chekhun, NY Lukianova, SV Chekhun, NO Bezdieniezhnykh, ...
Experimental Oncology, 2017
232017
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
VF Chekhun, IV Zalutskii, LA Naleskina, NY Lukianova, TM Yalovenko, ...
Experimental oncology, 2015
182015
Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
TV Zadvornyi, NY Lukianova, TV Borikun, VF Chekhun
Experimental oncology, 2018
162018
Association of circulating miR-21,-205, and-182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment
VF Chekhun, TV Borikun, VМ Bazas, AV Andriiv, OМ Klyusov, ...
Experimental Oncology 42 (3), 162-166, 2020
152020
Tumor microenvironment-derived miRNAs as prognostic markers of breast cancer
NY Lukianova, TV Borikun, VF Chekhun
Experimental Oncology 41 (3), 242-247, 2019
142019
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
VF Chekhun, NY Lukianova, TV Borikun, TV Zadvornyi, A Mokhir
Experimental Oncology, 2017
132017
Effect of 5-azacytidine on miRNA expression in human breast cancer cells with different sensitivity to cytostatics
VF Chekhun, TV Borikun, NY Lukianova
Experimental oncology, 2016
122016
Manifestation of key molecular genetic markers in pharmacocorrection of endogenous iron metabolism in MCF-7 and MCF-7/DDP human breast cancer cells
V Shvets, Yu., Chekhun, N Lukianova, D Demash, T Borikun, S Chekhun
CellBio 2 (4), 217-27, 2013
12*2013
Influence of exogenous lactoferrin on the oxidant/antioxidant balance and molecular profile of hormone receptor-positive and-negative human breast cancer cells in vitro
IV Zalutski, NY Lukianova, DM Storchai, AP Burlaka, YV Shvets, ...
Experimental Oncology, 2017
112017
In vitro study of toxicity of hybrid gold-polymer composites
N Kutsevol, Y Harahuts, I Shton, T Borikun, D Storchai, N Lukianova, ...
Molecular Crystals and Liquid Crystals 671 (1), 1-8, 2018
102018
Expression of markers of bone tissue remodeling in breast cancer and prostate cancer cells in vitro
N Lukianova, T Zadvornyi, E Kashuba, T Borikun, О Mushii, V Chekhun
Experimental Oncology 44 (1), 39-46, 2022
92022
Expression of microRNA in tumor cells of endmetrioid carcinoma of endometrium
LG Buchynska, TV Borykun, NP Iurchenko, SV Nespryadko, IP Nesina
Experimental Oncology 42 (4), 289-294, 2020
92020
NANOG as prognostic factor of prostate cancer course
TV Zadvornyi, NY Lukianova, TV Borikun, YV Vitruk, EO Stakhovsky, ...
Experimental Oncology 42 (2), 94-100, 2020
82020
Application of new multicomponent nanosystems for overcoming doxorubicin resistance in breast cancer therapy
N Kutsevol, Y Kuziv, T Bezugla, P Virych, A Marynin, T Borikun, ...
Applied Nanoscience, 1-11, 2021
72021
Effects of dextran-graft-polyacrylamide/ZnO nanoparticles on prostate cancer cell lines in vitro
PA Virych, TV Zadvornyi, TV Borikun, OO Lykhova, VA Chumachenko, ...
Experimental Oncology 44 (3), 217-221, 2022
52022
PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS’AGE
N Lukianova, O Mushii, T Borikun, T Zadvornyi, V Bazas, M Krotevych, ...
Experimental Oncology 45 (1), 17-27, 2023
42023
Mast cells as a tumor microenvironment factor associated with the aggressiveness of prostate cancer.
T Zadvornyi, N Lukianova, T Borikun, A Tymoshenko, O Mushii, ...
Neoplasma 69 (6), 2022
42022
The study of prognostic value of microRNAs (miR-10b and-155) and CDKN2A/P16INK4A in oral squamous cell carcinoma
О Kravets, O Burtyn, T Borikun, O Rossylna
Experimental Oncology 45 (2), 187-194, 2023
32023
Expression pattern of miR-125b-2,-155,-221, and-320a is associated with response of breast cancer patients to tamoxifen
O Pridko, T Borikun, O Rossylna, M Rishko, AV Rusyn
Experimental Oncology 44 (4), 295-299, 2022
32022
Expression of osteopontin and osteonectin in breast and prostate cancer cells with different sensitivity to doxorubicin
T Zadvornyi, N Lukianova, T Borikun, S Gogol, P Virych, O Lykhova, ...
Experimental Oncology 44 (2), 107-112, 2022
32022
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20